001     145039
005     20240321221023.0
024 7 _ |a 10.1002/mds.27987
|2 doi
024 7 _ |a pmid:31994808
|2 pmid
024 7 _ |a 0885-3185
|2 ISSN
024 7 _ |a 1531-8257
|2 ISSN
024 7 _ |a altmetric:74719672
|2 altmetric
037 _ _ |a DZNE-2020-00399
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Faber, Jennifer
|0 P:(DE-2719)2811327
|b 0
|e First author
|u dzne
245 _ _ |a Prominent White Matter Involvement in Multiple System Atrophy of Cerebellar Type.
260 _ _ |a New York, NY
|c 2020
|b Wiley
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2020-01-29
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2020-05-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1709651942_29111
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Sporadic degenerative ataxia patients fall into 2 major groups: multiple system atrophy with predominant cerebellar ataxia (MSA-C) and sporadic adult-onset ataxia (SAOA). Both groups have cerebellar volume loss, but little is known about the differential involvement of gray and white matter in MSA-C when compared with SAOA.The objective of this study was to identify structural differences of brain gray and white matter between both patient groups.We used magnetic resonance imaging to acquire T1-weighted images and diffusion tensor images from 12 MSA-C patients, 31 SAOA patients, and 55 healthy controls. Magnetic resonance imaging data were analyzed with voxel-based-morphometry, tract-based spatial statistics, and tractography-based regional diffusion tensor images analysis.Whole-brain and cerebellar-focused voxel-based-morphometry analysis showed gray matter volume loss in both patient groups when compared with healthy controls, specifically in the cerebellar areas subserving sensorimotor functions. When compared with controls, the SAOA and MSA-C patients showed white matter loss in the cerebellum, whereas brainstem white matter was reduced only in the MSA-C patients. The tract-based spatial statistics revealed reduced fractional anisotropy within the pons and cerebellum in the MSA-C patients both in comparison with the SAOA patients and healthy controls. In addition, tractography-based regional analysis showed reduced fractional anisotropy along the corticospinal tracts in MSA-C, but not SAOA.Although in our cohort extent and distribution of gray and white matter loss were similar between the MSA-C and SAOA patients, magnetic resonance imaging data showed prominent microstructural white matter involvement in the MSA-C patients that was not present in the SAOA patients. Our findings highlight the significance of microstructural white matter changes in the differentiation between both conditions. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2020-01-29
|2 Crossref
|u http://creativecommons.org/licenses/by/4.0/
542 _ _ |i 2020-01-29
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Atrophy: pathology
|2 MeSH
650 _ 2 |a Cerebellum: diagnostic imaging
|2 MeSH
650 _ 2 |a Cerebellum: pathology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Image Processing, Computer-Assisted
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
650 _ 2 |a Multiple System Atrophy: diagnostic imaging
|2 MeSH
650 _ 2 |a Multiple System Atrophy: pathology
|2 MeSH
650 _ 2 |a White Matter: diagnostic imaging
|2 MeSH
650 _ 2 |a White Matter: pathology
|2 MeSH
700 1 _ |a Giordano, Ilaria
|0 P:(DE-2719)2811662
|b 1
|u dzne
700 1 _ |a Jiang, Xueyan
|0 P:(DE-2719)2811945
|b 2
|u dzne
700 1 _ |a Kindler, Christine
|0 P:(DE-2719)9000373
|b 3
|u dzne
700 1 _ |a Spottke, Annika
|0 P:(DE-2719)2811324
|b 4
|u dzne
700 1 _ |a Acosta-Cabronero, Julio
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Nestor, Peter J
|0 P:(DE-2719)2810673
|b 6
|u dzne
700 1 _ |a Machts, Judith
|0 P:(DE-2719)2810317
|b 7
|u dzne
700 1 _ |a Düzel, Emrah
|0 P:(DE-2719)2000005
|b 8
|u dzne
700 1 _ |a Vielhaber, Stefan
|0 P:(DE-2719)2000035
|b 9
|u dzne
700 1 _ |a Speck, Oliver
|0 P:(DE-2719)2810706
|b 10
|u dzne
700 1 _ |a Dudesek, Ales
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Kamm, Christoph
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Scheef, Lukas
|0 P:(DE-2719)2811377
|b 13
|u dzne
700 1 _ |a Klockgether, Thomas
|0 P:(DE-2719)2810314
|b 14
|e Last author
|u dzne
773 1 8 |a 10.1002/mds.27987
|b : Wiley, 2020-01-29
|n 5
|p 816-824
|3 journal-article
|2 Crossref
|t Movement Disorders
|v 35
|y 2020
|x 0885-3185
773 _ _ |a 10.1002/mds.27987
|g Vol. 35, no. 5, p. 816 - 824
|0 PERI:(DE-600)2041249-6
|n 5
|p 816-824
|t Movement disorders
|v 35
|y 2020
|x 0885-3185
856 4 _ |u https://pub.dzne.de/record/145039/files/DZNE-2020-00399.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/145039/files/DZNE-2020-00399.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:145039
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811327
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2811662
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2811945
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000373
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811324
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2810673
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2810317
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2000005
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2000035
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2810706
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)2811377
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2810314
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-02-26
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2020-02-26
|w ger
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-11
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOVEMENT DISORD : 2021
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-11
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-11
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MOVEMENT DISORD : 2021
|d 2022-11-11
920 1 _ |0 I:(DE-2719)1011101
|k Patient Studies Bonn
|l Patient Studies Bonn
|x 0
920 1 _ |0 I:(DE-2719)1310001
|k AG Nestor
|l Cognitive Neurology and Neurodegeneration
|x 1
920 1 _ |0 I:(DE-2719)1340009
|k AG Speck
|l Linking imaging projects iNET
|x 2
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 3
920 1 _ |0 I:(DE-2719)1011202
|k AG Boecker
|l Positron Emissions Tomography (PET)
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a I:(DE-2719)1310001
980 _ _ |a I:(DE-2719)1340009
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a I:(DE-2719)1011202
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s004390000346
|2 Crossref
|o 10.1007/s004390000346
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.51.6.1666
|2 Crossref
|o 10.1212/WNL.51.6.1666
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awf107
|2 Crossref
|o 10.1093/brain/awf107
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s004010050918
|2 Crossref
|o 10.1007/s004010050918
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1365-2990.2007.00907.x
|2 Crossref
|o 10.1111/j.1365-2990.2007.00907.x
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000324625.00404.15
|2 Crossref
|o 10.1212/01.wnl.0000324625.00404.15
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-007-0556-1
|2 Crossref
|o 10.1007/s00415-007-0556-1
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0022-510X(81)90104-0
|2 Crossref
|o 10.1016/0022-510X(81)90104-0
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000117052
|2 Crossref
|o 10.1159/000117052
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1440-1789.2007.00845.x
|2 Crossref
|o 10.1111/j.1440-1789.2007.00845.x
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0000000000004311
|2 Crossref
|o 10.1212/WNL.0000000000004311
999 C 5 |9 -- missing cx lookup --
|a 10.1016/B978-0-444-64189-2.00014-7
|2 Crossref
|o 10.1016/B978-0-444-64189-2.00014-7
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.20656
|2 Crossref
|o 10.1002/mds.20656
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneur.62.6.981
|2 Crossref
|o 10.1001/archneur.62.6.981
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awh013
|2 Crossref
|o 10.1093/brain/awh013
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.21229
|2 Crossref
|o 10.1002/mds.21229
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00330-018-5594-9
|2 Crossref
|o 10.1007/s00330-018-5594-9
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-015-7934-x
|2 Crossref
|o 10.1007/s00415-015-7934-x
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2007.04.028
|2 Crossref
|o 10.1016/j.neuroimage.2007.04.028
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.nicl.2019.101891
|2 Crossref
|o 10.1016/j.nicl.2019.101891
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.parkreldis.2017.03.001
|2 Crossref
|o 10.1016/j.parkreldis.2017.03.001
999 C 5 |9 -- missing cx lookup --
|a 10.1016/bs.irn.2018.08.010
|2 Crossref
|o 10.1016/bs.irn.2018.08.010
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00234-010-0757-7
|2 Crossref
|o 10.1007/s00234-010-0757-7
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s13760-016-0724-0
|2 Crossref
|o 10.1007/s13760-016-0724-0
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.20255
|2 Crossref
|o 10.1002/mds.20255
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000219042.60538.92
|2 Crossref
|o 10.1212/01.wnl.0000219042.60538.92
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12311-012-0421-3
|2 Crossref
|o 10.1007/s12311-012-0421-3
999 C 5 |9 -- missing cx lookup --
|a 10.1006/nimg.2000.0582
|2 Crossref
|o 10.1006/nimg.2000.0582
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2009.01.045
|2 Crossref
|o 10.1016/j.neuroimage.2009.01.045
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2004.07.051
|2 Crossref
|o 10.1016/j.neuroimage.2004.07.051
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2007.07.007
|2 Crossref
|o 10.1016/j.neuroimage.2007.07.007
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2006.02.024
|2 Crossref
|o 10.1016/j.neuroimage.2006.02.024
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0049790
|2 Crossref
|o 10.1371/journal.pone.0049790
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0133402
|2 Crossref
|o 10.1371/journal.pone.0133402
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nrneurol.2017.26
|2 Crossref
|o 10.1038/nrneurol.2017.26
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.21032
|2 Crossref
|o 10.1002/mds.21032
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2004.11.022
|2 Crossref
|o 10.1016/j.neuroimage.2004.11.022
999 C 5 |y 2001
|2 Crossref
|o Villanueva‐Haba V 2001
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.43.2.318
|2 Crossref
|o 10.1212/WNL.43.2.318
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneur.60.10.1431
|2 Crossref
|o 10.1001/archneur.60.10.1431
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000249307.59950.f8
|2 Crossref
|o 10.1212/01.wnl.0000249307.59950.f8
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2004.01.035
|2 Crossref
|o 10.1016/j.neuroimage.2004.01.035
999 C 5 |9 -- missing cx lookup --
|a 10.3174/ajnr.A1662
|2 Crossref
|o 10.3174/ajnr.A1662
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.21465
|2 Crossref
|o 10.1002/ana.21465
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mdc3.12404
|2 Crossref
|o 10.1002/mdc3.12404


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21